This change of control event subordinates Bio-Techne's strategy and leadership to its new parent, Merck KGaA.
Filing excerpt
On June 25, 2026, Bio-Techne Corporation, a Minnesota corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Merck KGaA, Darmstadt, Germany, a German corporation with general partners (“Parent”), and EMD Holdings NewCo, Inc., a Minnesota corporation and a wholly-owned subsidiary of Parent (“Merger Sub”).
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kgovernanceChangeGet every 8-K signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/75c0f7d5-8eaa-4f4a-9645-84fa5b5e276e returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "75c0f7d5-8eaa-4f4a-9645-84fa5b5e276e",
"signal_type": "sec-8k",
"signal_subtype": "governanceChange",
"detected_at": "2026-06-30T07:07:40.498+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "This change of control event subordinates Bio-Techne's strategy and leadership to its new parent, Merck KGaA. Such acquisitions typically trigger a comprehensive review of all strategic initiatives, budgets, and vendor contracts, creating significant risk for incumbents and opportunities for new partners supporting post-merger integration.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "The merger consideration is $73.00 in cash per share of the Company's common stock."
},
"summary": "Bio-Techne to be acquired by Merck KGaA and become a wholly-owned subsidiary.",
"excerpts": "On June 25, 2026, Bio-Techne Corporation, a Minnesota corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Merck KGaA, Darmstadt, Germany, a German corporation with general partners (“Parent”), and EMD Holdings NewCo, Inc., a Minnesota corporation and a wholly-owned subsidiary of Parent (“Merger Sub”).",
"relevance": 1,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000199937126013527/tech-8k_062326.htm",
"filing_date": "2026-06-25",
"filing_year": 2026,
"sales_relevance": "Governance tools needed",
"signal_category": "esg"
}
}
curl https://signals.autobound.ai/v1/signals/75c0f7d5-8eaa-4f4a-9645-84fa5b5e276e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.